Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Esteban Rubio-Romero"'
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-17 (2024)
Abstract Background To describe the evidence of methotrexate (MTX) initiation strategies in patients with rheumatoid arthritis (RA) and, in the case of non-responders, analyse the efficacy and safety of route and dose optimisation. Methods We conduct
Externí odkaz:
https://doaj.org/article/c7e4b11ac5dc4d819470a15a83f1a5a5
Autor:
Blanca Hernández Cruz, Inmaculada Ureña Garnica, Ricardo Sánchez Parera, Esteban Rubio Romero, Jerusalén Calvo Gutiérrez, Antonio García Sánchez, Carlos Rodríguez Escalera, Federico Navarro Sarabia
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss 4, Pp 149-157 (2020)
Externí odkaz:
https://doaj.org/article/ed7b962390a44b3cbcab065780e38b44
Autor:
Santos Castañeda, Lucía Martínez-Costa, Emma Beltrán, María Álvarez del Buergo, L Domínguez-Casas, Miguel A. González-Gay, Ruth López-González, Esteban Rubio-Romero, Ángel García-Aparicio, Ricardo Blanco, L. Sanchez-Bilbao, N. Vegas-Revenga, José L. Hernández, David Díaz-Valle, Antonio Juan Mas, R. Demetrio-Pablo, Ana Blanco, O. Maíz, Vanesa Calvo-Río
Publikováno v:
Seminars in Arthritis and Rheumatism. 50:608-615
Purpose We assessed the efficacy and safety of biologic therapy in severe and refractory Peripheral Ulcerative Keratitis (PUK). Design Open-label multicenter study of biologic-treated patients with severe PUK refractory to conventional immunosuppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7942707002a2fa6b67c80d69cfc24ae
https://doi.org/10.1016/j.semarthrit.2020.03.023
https://doi.org/10.1016/j.semarthrit.2020.03.023
Autor:
Fernando J. Martinez, Conrad Pujol, J. Notario, Francisco Maceiras, Esteban Rubio Romero, Laura Rodríguez Pazos, Jesús Rodríguez, Antonio Vélez García-Nieto, Merce Hergueta, Jose Luis Alvarez Vega, Pablo de la Cueva, Jordi Gratacós, José Pardo Sánchez, Basilio Narváez Moreno, Lourdes Rodríguez Fernandez Freire, Teresa Navío Marco, Silvia Pérez Barrio, Rubén Queiro, Jesús Luelmo, Ana Urruticoechea-Arana, Pablo Coto, Carlos Manuel Feced Olmos, Raquel Rivera, Beatriz Joven, Mercè García Font, Eva Galindez, Manel Pujol Busquets, M. Dolores López Montilla
Publikováno v:
Reumatología Clínica. 16:24-31
Resumen Objetivo 1) Analizar la implementacion de los modelos de atencion multidisciplinar en pacientes con artritis psoriasica (APs), y 2) definir estandares de calidad de minimos y de excelencia. Metodos Se envio una encuesta a profesionales que ya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed96b4d9db5d8b9376768a4ebe33f033
https://doi.org/10.1016/j.reuma.2018.01.010
https://doi.org/10.1016/j.reuma.2018.01.010
Publikováno v:
Reumatología Clínica
Resumen El desenlace de la infeccion por SARS-CoV-2 (COVID-19) afecta fundamentalmente al campo pulmonar, ocasionando un cuadro de sindrome de distres respiratorio agudo (SDRA). Este proceso es un cuadro inflamatorio protagonizado por una cascada de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595384d05daa3da192fcac547a92d1ce
Autor:
Antonio Gómez-Centeno, Santiago Muñoz-Fernández, Ceferino Barbazán-Álvarez, Sagrario Bustabad, Sara Manrique-Arija, Esteban Rubio-Romero, Juan Amarelo-Ramos, Juan Ovalles, Javier del Pino-Montes, Sara Marsal-Barril
Publikováno v:
Rheumatology International. 39:2015-2024
To describe the clinical and therapeutic management of rheumatoid arthritis (RA) patients with biological disease-modifying antirheumatic drugs (bDMARDs), alone or in combination with conventional synthetic DMARDs (csDMARDs), as well as analysing cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6200291d66046f1771d920d38a7ab4c
https://doi.org/10.1007/s00296-019-04378-6
https://doi.org/10.1007/s00296-019-04378-6
Publikováno v:
Reumatologi´a Clinica
The outcome of the SARS-CoV-2 (COVID-19) infection fundamentally affects the lung field, causing ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS). This process is an inflammatory picture, involving an NLRP3 INFLAMOSOME-triggered cytokine storm, the main pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c211cf4a224e36c11d11f82466fae537
http://europepmc.org/articles/PMC8041148
http://europepmc.org/articles/PMC8041148
Autor:
Miriam García-Arias, Joan M. Nolla, Jose M. Herreras, Belén Atienza-Mateo, Fernando Jiménez-Zorzo, Vanesa Calvo-Río, F. Luis, Miguel A. González-Gay, Monica Calderón-Goercke, Enrique Minguez, J. Luis Hernández, Alfredo Adán, Santos Insua, O. Maiz-Alonso, Diana Peiteado, Fernando Gamero, Marcelino Revenga, D. Prieto-Peña, Lara Sánchez Bilbao, Emma Beltrán, Elena Aurrecoechea, L. F. Linares Ferrando, José L. García-Serrano, Alejandro Olivé, Elia Valls-Pascual, Juan Mendózar Cruz, Carmen Carrasco-Cubero, Cristina Fernández-Carballido, A. Sanchez-Andrade, Francisco Javier López-Longo, Norberto Ortego, Santiago Muñoz Fernández, Esperanza Pato, Vega Jovani, Julio Vázquez, Cruz Fernandez-Espartero, Fred Antón Pages, Juan Sánchez-Bursón, Enrique Raya, Ignacio Torre-Salaberri, Manuel Diaz-Llopis, Angel Garcia-Aparicio, Agusti Sellas-Fernández, Esteban Rubio-Romero, C. A. Montilla-Morales, Oscar Ruiz-Moreno, Lucia Martinez-Costa, A. Javier García-González, R. Demetrio-Pablo, Roberto Gallego, F. Francisco, Fredeswinda Romero, Ana Blanco, Alejandro Fonollosa, José Luis Martín-Varillas, Marina Mesquida, Toyos Sáenz de Miera, Senen González-Suárez, Myriam Gandia Martinez, Marisa Hernández-Garfella, Miguel Cordero-Coma, Miguel A. Caracuel-Ruiz, Javier Manero, Antonio Atanes-Sandoval, Carlos Férnandez-Cid, David Díaz Valle, I. González-Mazón, J. Francisco, Santos Castañeda, Raquel Almodóvar, V. Hernandez, Ricardo Blanco
Publikováno v:
Poster Presentations.
Background Uveitis is one of the major causes of disability of Behcet’s disease (BD). According to the “Expert panel recommendations”, anti-TNF therapy with infliximab (IFX) or adalimumab (ADA) may be considered as first- or second-line therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::159d7c748670484b25b546f7418a521c
https://doi.org/10.1136/annrheumdis-2019-eular.1606
https://doi.org/10.1136/annrheumdis-2019-eular.1606
Autor:
Belén Atienza-Mateo, Esteban Rubio Romero, Ricardo Blanco, Miguel A. González-Gay, Luis Fernández-Dominguez, B. Joven-Ibáñez, Beatriz Arca, Alfonso Corrales, Clara Ventin-Rodriguez, José Luis Martín-Varillas, Jose Campos Esteban, Antia Crespo Golmar, Francisco Ortiz-Sanjuán, Maria Jose Moreno, Manuel Moreno, Eva Galindez, O. Maíz, Rafael Melero, Agusti Sellas-Fernández, Raul Veroz Gonzalez, Enrique Raya, Roberto Daniel Gonzalez Benitez, Olga Rusinovich, Alejandro Escudero Contreras, Emma Beltrán, Vanesa Calvo-Río, Natalia Palmou-Fontana, Javier Loricera, Ximena Elizabeth Larco Rojas, María-Luisa Peral
Publikováno v:
Abstracts accepted for Publication.
Background: Tofacitinib (TOFA) is the first inhibitor of JAK kinases with approval for the treatment of psoriatic arthritis (PsA) in Europe (July 2018)1. ToFA has shown efficacy in refractory patients to anti-TNF2. Objectives: A) to assess efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bacfa1479a5769dfa23f37f5a822b1c
https://doi.org/10.1136/annrheumdis-2019-eular.7803
https://doi.org/10.1136/annrheumdis-2019-eular.7803
Autor:
Alberto Ruiz Román, Clara Aguilera Cros, Juan Povedano Gomez, Maria Dolores Arcila Duran, Marina Gomez Vargas, Isabel Madroñal García, Esteban Rubio Romero, Lara Mendez
Publikováno v:
Abstracts Accepted for Publication.
Background Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder of unknown aetiology, and approximately 60% or 70% of the patients can develop a chronic poliphasic form of the disease or a chronic polyarthritis. Due to the ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd3b98193b674420cf238eb3949a4b6f
https://doi.org/10.1136/annrheumdis-2019-eular.4904
https://doi.org/10.1136/annrheumdis-2019-eular.4904